证券研究报告 2025年05月15日 行业报告 | 行业专题研究 医药生物 医药行业2024年报&2025一季报业绩分析—— 医疗服务板块 作者： 分析师 杨松 SAC执业证书编号：S1110521020001 分析师 李慧瑶 SAC执业证书编号：S1110522080004 1 行业评级： 上次评级： 强于大市 强于大市 维持 （ 评级） 请务必阅读正文之后的信息披露和免责申明 摘要：基数影响2024业绩承压，宏观环境改善有望带动持续修复 ➢ 2024年医疗服务板块表现承压 医疗服务板块我们合计梳理17家上市公司，2024年医疗服务板块整体营业收入739.08亿元，同比增长 1.29%；归母净利润48.57亿元，同比-16.37%；扣非归母净利润42.29亿元，同比-22.95%。 ➢ 2025年Q1医疗服务需求回稳，利润端持续改善 2025年Q1医疗服务板块整体营业收入180.05亿元，同比增长2.48%；归母净利润13.25亿元，同比增长 16.24%；扣非归母净利润12.66亿元，同比增长18.21%。 ➢ 毛利率略有下滑 2024年板块毛利率为37.02%，同比-1.24pct，2025Q1板块毛利 ...

Tenet Healthcare (THC) 2025 Conference May 13, 2025 01:40 PM ET Speaker0 Everyone, thanks so much for joining our BOA Healthcare Conference. My name is Joanna Gajuk, I cover healthcare facilities and managed care at BOA. And now it's my pleasure to host this session with Tenet Healthcare, who is one of the largest healthcare system operators with a growing and pretty big ASC platform. So we're going to talk about that. And today with us, we have Will, who's going to introduce the speakers and have some intr ...

DaVita Inc. (DVA) delivered adjusted earnings per share (EPS) of $2.00 in the first quarter of 2025, down 11.5% year over year. However, the figure surpassed the Zacks Consensus Estimate by 14.3%.GAAP EPS for the quarter was $2.00, reflecting a plunge of 24.5% year over year.DaVita’s Revenues in DetailRevenues of $3.22 billion in the first quarter increased 4.9% year over year. The figure topped the Zacks Consensus Estimate by 0.4%.Revenue per treatment in the first quarter of 2025 was $400.1 million, up 4. ...

5月13日，国际医学今日收盘5.29元，上涨2.52%，最新市净率3.35，创14天以来新低，总市值119.57亿 元。 截至2025年一季报，共有10家机构持仓国际医学，其中其他5家、基金4家、券商1家，合计持股数 75944.78万股，持股市值41.39亿元。 西安国际医学投资股份有限公司的主营业务是大健康医疗服务和现代医学技术转化应用。公司的主要产 品是医疗业、软件和信息技术服务业、其他社会服务业、商品流通业。公司及子公司荣膺多项荣 誉："2024届标杆医院研究成果社会办医·单体医院100强"、"海峡两岸及港澳社会办医院100强"、"首批 西部社会办医标杆医院"、"2024年度最佳投关奖"、"西安市三八红旗集体"、"现代服务业优秀企业"等 众多荣誉。 最新一期业绩显示，2025年一季报，公司实现营业收入9.97亿元，同比-14.99%；净利润-106353858.88 元，同比-1.37%，销售毛利率5.21%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)7国际医学-46.79-47.053.35119.57亿行业平均 38.5745.023.42152.74亿行业中值38.1250.592 ...

2025 年 05 月 13 日 投资要点 分析师：孟之绪 执业编号：S0300524080001 电话： 邮箱：mengzhixu@ykzq.com 证券研究报告 | 策略点评 投资策略研究 粤开市场日报-20250513 今日关注 指数涨跌情况：今日 A 股主要宽基指数涨少跌多。截止收盘，沪指涨 0.17%， 收报 3374.87 点；深证成指跌 0.13%，收报 10288.08 点；创业板指跌 0.12%， 收报 2062.26 点；科创 50 跌 0.15%，收报 1009.68 点。总体上全天个股涨少 跌多，Wind 数据显示，全市场 1940 只个股上涨，3233 只个股下跌，237 只个 股收平。沪深两市今日成交额合计 12915 亿元，较上个交易日缩量约 169 亿 元。 行业涨跌情况：今日申万一级行业涨多跌少，银行、美容护理、医药生物、 交通运输和煤炭行业领涨，涨幅分别为 1.52%、1.18%、0.90%、0.72%和 0.62%， 国防军工、计算机、机械设备、电子和通信行业领跌，跌幅分别为 3.07%、0.80%、 0.66%、0.64%和 0.61%。 板块涨跌情况：今日涨幅居前概念 ...

AMN Healthcare Services, Inc. (AMN) delivered adjusted earnings per share (EPS) of 45 cents in the first quarter of 2025, which declined 53.6% year over year. However, the figure surpassed the Zacks Consensus Estimate by 136.8%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)GAAP loss per share for the quarter was 3 cents against EPS of 45 cents in the year-ago period.AMN’s Revenues in DetailAMN Healthcare registered revenues of $689.5 million in the first quarter, down 16% year ov ...

5月9日，国际医学今日收盘5.12元，下跌2.10%，最新市净率3.24，总市值115.73亿元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)7国际医学-45.28-45.543.24115.73亿行业平均 38.0043.993.36149.92亿行业中值38.3648.452.6151.49亿1润达医疗-302.80200.382.61110.77亿2何氏眼 科-135.47-117.891.6932.30亿3*ST生物-113.75-110.589.3421.95亿4普瑞眼科-68.75-61.762.9562.91亿5诚达 药业-68.44-117.261.5432.95亿6皓宸医疗-50.22-60.405.9622.76亿8创新医疗-40.76-45.512.4342.76亿9金域 医学-36.41-37.282.06142.13亿10百诚医药-29.67-72.441.5038.21亿11迪安诊断-22.22-24.961.3689.18亿 来源：金融界 股东方面，截至2025年3月31日，国际医学股东户数109907户，较上次增加4413户，户均持股市值35.28 万元，户均持股数 ...

Shares of Teladoc Health Inc. (TDOC) have fallen 4.6% since it reported first-quarter 2025 results on April 30, as investors are not impressed with its 2025 outlook. Although it reported better-than-expected results due to growing international revenues and an expanding membership base in the Integrated Care segment, the upsides were partially offset by lower access fees and fewer visits.Teladoc Health incurred a first-quarter 2025 adjusted loss of 19 cents per share, narrower than the Zacks Consensus Estim ...

Privia Health Group (PRVA) Q1 2025 Earnings Call May 08, 2025 08:00 AM ET Company Participants Robert Borchert - SVP, Investor and Corporate CommunicationsParth Mehrotra - CEODavid Mountcastle - EVP & CFOJailendra Singh - Managing DirectorJoshua Raskin - Partner - Managed Care & ProvidersRichard Close - Managing DirectorAlberta Massey - Equity Research AssociateA.J. Rice - Managing DirectorThomas Walsh - Equity Research AssociateConstantine Davides - Managing DirectorJack Slevin - VP - Healthcare Services E ...